Effect of a single dose (600 MG) of albendazole on Loa loa microfilaraemia

Parasite

Volumn 9, Issue 1, 2002, Pages 59-63

  Kamgno, J ^a   Boussinesq, M ^a  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

Author keywords

Albendazole; Clinical trial; Ivermectin; Loa loa; Loiasis; Onchocerciasis; Side effects

Indexed keywords

LOA; LOA LOA;

ALBENDAZOLE; ANTIFILARIAL AGENT; MEBENDAZOLE;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FAT INTAKE; FEMALE; FILARIASIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; LOA; MALE; MICROFILARIA; MIDDLE AGED; PARASITEMIA; PARASITOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; CHILD; DIETARY FATS; FEMALE; FILARICIDES; HUMANS; LOA; LOIASIS; MALE; MEBENDAZOLE; MICROFILARIA; MIDDLE AGED; PARASITEMIA; TREATMENT OUTCOME;

EID: 0036516251     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/200209159     Document Type: Article

References (20)

1. AUBUCHON J.P. & DZIK W.H. Survival of Loa loa in banked blood. Lancet, 1983, 1, 647-648.
2. AWADZI K., HERO M., OPOKU O., BÜTTNER D.W. & GILLES H.M. The chemotherapy of onchocerciasis XV. Studies with albendazole. Tropical Medicine and Parasitology, 1991, 42, 356-360.
3. AWADZI K., HERO M., OPOKU N.O., BÜTTNER D.W., COVENTRY P.A., PRIME M.A., ORME M.L.E. & EDWARDS G. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Tropical Medicine and Parasitology, 1994, 45, 203-208.
4. BLUM J., WIESTNER A., FUHR P. & HATZ C. Encephalopathy following Loa loa treatment with albendazole. Acta Tropica, 2001, 78, 63-65.
5. BOUSSINESQ M., GARDON J., GARDON-WENDEL N., KAMGNO J., NGOUMOU P. & CHIPPAUX J.P. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. American Journal of Tropical Medicine and Hygiene, 1998, 58, 461-469.
6. CLINE B.L., HERNANDEZ J.L., MATHER F.J., BARTHOLOMEW R., NUNEZ DE MAZA S., RODULFO S., WELBORN C.A., EBERHARD M.L. & CONVIT J. Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela. American Journal of Tropical Medicine and Hygiene, 1992, 47, 512-520.
7. DUKE B.O.L. Studies on loiasis in monkeys. II. - The population dynamics of the microfilariae of Loa in experimentally infected drills (Mandrillus leucopbaeus). Annals of Tropical Medicine and Parasitology, I960, 54, 15-31.
8. DUNYO S.K., NKRUMAH F.K. & SIMONSEN P.E. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000a, 94, 205-211.
9. DUNYO S.K., NKRUMAH F.K. & SIMONSEN P.E. Single-dose treatment of Wuchereria bancrofii infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000b, 94, 437-443.
10. FOBI G., GARDON J., SANTIAGO M., DEMANGA NGANGUE, GARDON-WENDEL N. & BOUSSINESQ M. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiology, 2000, 7, 27-39.
11. FULLEBORN F. Untersuchungen an menschlichen Filarien und deren Ubertragung auf Stechmücken. Archiv für Schiffsund Tropen-Hygiene, 1908, 12, 5-43.
12. GARCIA A., ABEL L., COT M., RANQUE S., RICHARD P., BOUSSINESQ M. & CHIPPAUX J.P. Longitudinal survey of Loa loa filariasis in Southern Cameroon: long-term stability and factors influencing individual microfilarial status. American Journal of Tropical Medicine and Hygiene, 1995, 52, 370-375.
13. GARDON J., GARDON-WENDEL N., DEMANGA-NGANGUE, KAMGNO J., CHIPPAUX J.P. & BOUSSINESQ M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet, 1997, 350, 18-22.
14. GÖNNERT R. Zur Lebensdauer menschlicher Mikrofilarien. Zentralblatt für Bakteriologie, Parasitenkunde und Infektionskrankheiten, 1942, 149, 75-81.
15. ISMAIL M.M., JAYAKODY R.L., WEIL G.J., NIRMALAN N., JAYASINGHE K.S.A., ABEYEWICKREMA W., REZVI SHERIFF M.H., RAJARATNAM H.N., AMARASEKERA N., DE SILVA D.C.L, MICHALSKI M.L. & DISSANAIKE A.S. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1998, 92, 94-97.
16. JAYAKODY R.L., DE SILVA C.S.S. & WEERASINGHE W.M.T. Treatment of bancroftian filariasis with albendazole: evaluation of efficacy and adverse reactions. Tropical Biomedicine, 1993, 10, 19-24.
17. KLION A.D., MASSOUGBODJI A., HORTON J., EKOUE S., LANMASSO T., AHOUISSOU N.L. & NUTMAN T.B. Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. Journal of Infectious Diseases, 1993, 168, 202-206.
18. LANGE H., EGGERS R. & BIRCHER J. Increased systemic availability of albendazole when taken with a fatty meal. European Journal of Clinical Pharmacology, 1988, 34, 315-317.
19. SHARP D. Another tropical-drug donation. Lancet, 1998, 351, 388.
20. WILLIAMS C.B. The use of logarithms in the interpretation of certain entomological problems. Annals of Applied Biology, 1937, 24, 404-414.